Dumaog, Leighton Jayce M.
HRN: 25-67-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/17/2024
10/23/2024
IV
33mg
OD
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes